of anti-inflammatory activity. 3 One of the main tasks of IL-10 is to maintain the immune balance within the structures of the gastrointestinal tract 4, 5 and to reduce inflammation in the mechanism of autocrine signaling. 3 CD is one of the most common food enteropathies. Its prevalence is 1:100 and 1:300 in the adult population of North America and Europe, respectively, and its incidence is estimated at 2-13/100 000 per year.
6-9 The disease affects individuals at any age, but most cases are diagnosed in early childhood and between 30 and 40 years of age. Despite significant development of diagnostic methods, the number of patients suffering from CD remains underestimated. The ratio of diagnosed to undiagnosed population is 1:5-10. [6] [7] [8] [9] The spectrum of clinical symptoms in the course of CD is very broad and encompasses gastrointestinal symptoms, such as diarrhea and abdominal distension, but also various other manifestations, including neurologic symptoms (TABLE 1) . 2, [10] [11] [12] [13] [14] [15] [16] The first reports of concomitant neurologic disorders within the central nervous system in patients affected with CD appeared more than 40 years ago, but only in the last few years, research on the occurrence of gluten -dependent peripheral neuropathy and disorders of the autonomic nervous system (ANS) has been conducted.
11,15,17,18
Neurologic and psychiatric symptoms have already been observed in 22% of patients with CD.
17
In their study, Isiskay et al 19 found neurologic symptoms in more than 13% of children suffering from CD. Moreover, it has also been determined that more than half of the patients with neurologic symptoms of unknown etiology have positive serological markers typical of CD. 20 Previous studies have also shown the occurrence of ANS disorders 21 and the simultaneous occurrence of these disorders with impairment of gastric myoelectrical activity.
22
The presence of antiganglioside antibodies in neurologic disorders has been reported. 23 A few study groups 11,17,23 have described the presence of these antibodies in some patients with CD, including patients with no neurologic symptoms. Gangliosides constitute a heterogeneous group of acidic glycolipids. They are located on the surface of neurons and perform diverse roles in a number of reactions. They have been classified as GM1, GM2, GD1a, GD1b, GT1b, and GQ1b.
24 Antibodies to GM1 and GD1a seem to play a key role in demyelinating processes. 24 Studies have confirmed that in the course of immune disorders, abnormalities in the nervous system were accompanied by changes in the concentration of neuron-specific enolase (NSE).
25
NSE belongs to glycolytic enzymes and participates, among others, in the mechanisms affecting the inhibition of inflammatory response.
26-30 In nervous system disorders, variations in the concentration of NSE were observed. Three subunits of enolase have so far been determined in higher eukaryotic representatives: alpha-enolase located and intestinal villous atrophy occur within the small intestine. The lesions lead to a reduction of the absorption surface in the small intestine.
1,2 Inflammatory lesions in patients with active CD are related to the response to gluten and are associated with the production of proinflammatory and anti-inflammatory cytokines such as interleukin 10 (IL-10), a pleiotropic cytokine NSE, and IL-10 concentrations in the course of CD and the variability of cardiac rhythm and gastric myoelectrical activity. The aim of this study was to evaluate the prevalence of anti-GM1 antibodies, NSE, and IL-10 concentrations in patients with CD without neurologic symptoms and in the control group of healthy subjects. The correlations between anti-GM1 antibodies, NSE, and IL-10 and heart rate variability (HRV) and myoelectrical activity were also investigated in the group of celiac patients.
PATIENTS AND METHODS Bioethics
The protocol of the study was approved by the Local Bioethics Committee at Jagiellonian University, Kraków, Poland (decision no. KBET/148/B/2012, as of May 24, 2012). All participants received written information about the assumptions and principles of in the majority of cells, beta-enolase specific for muscle cells, and gamma-enolase (NSE) associated with the cells of the nervous system.
25,26-30
An increase in NSE concentrations is observed in nervous system trauma, stroke, and malignancy related to the nervous system, for example, neuroendocrine tumors. 25, [26] [27] [28] [29] [30] In the course of some chronic diseases, such as lupus with neuropsychiatric symptoms, lower NSE concentrations were observed in comparison with healthy controls. 25 The correlation between IL-10 concentrations and the ANS response has been demonstrated in research. 4, 5 However, NSE and IL-10 concentrations have not been analyzed in adult celiac patients presenting with no neurologic symptoms. In additon, there has been no simultaneous comparative evaluation of antiganglioside antibodies, Abbreviations: DF, dominant frequency; DP, dominant power; EGG, electrogastrography; HRV, heart rate variability; LF, low frequency; HF, high frequency; PSD-HRV, power spectral density; SWC, single wave coupling
Due to motion artifacts, the number of patients in the celiac group, in which EGG and HRVwas performed, was reduced.
Medical history was taken and physical examination was performed in both groups. On the basis of the results, further proceedings were established and celiac patients were scheduled for a panendoscopic procedure.
Serological tests Immunoglobulin (Ig) A and IgG antiendomysial antibodies (anti-EmA) and/or antitissue transglutaminase (anti-tTG) and anti-GM1 antibodies were detected in serum. The concentrations of NSE and IL-10 were also determined. Anti-EmA and anti-tTG antibodies showed high specificity (90%-100% and 87%-97%) and sensitivity (95%-100% and 97%-100%, respectively). 1 All assays were performed according to the manufacturer's instructions.
Serum IgA EmA were detected by an immunofluorescence method. The titer above 1:10 was considered positive. Anti-tTG antibodies were assayed by an enzyme-linked immunosorbent assay (ELISA; Aesku Diagnostics GmbH, Germany). The test range was (permanently) from 0 to 300 U/ml. The concentration of antibodies equal to or higher than 15 U/ml indicated a positive result.
The serum NSE concentration was tested with an ELISA (Quantikine® ELISA Human Enolase 2/Neuron-specific Enolase Immunoassay, R&D Systems, Inc., Minneapolis, Minnesota, United States). The lowest minimum concentration (minimum detectable dose, MMD) of this assay ranged from 0.013 to 0.038 ng/ml, and the mean MMD was 0.02 ng/ml.
Anti-GM1 antibodies were detected by an ELISA test (Human Anti-ganglioside M1 Antibody ELISA Kit, ELAB, Bethesda, Maryland, United States). The assay detection range was from 3.090 to 250 ng/ml according to manufacturer's specifications.
The IL-10 concentration was determined by an ELISA test (Quantikine® ELISA Human IL-10, R&D Systems, Inc. Minneapolis, MN). The MMD was lower than 3.9 pg/ml.
Histological examination of distal duodenum mucosa
bioptates During panendoscopic biopsies, specimens were taken from the postbulbar duodenum (in accordance with current guidelines). After hematoxylin and eosin staining, the segments were assessed according to the modified Marsh classification (Oberhuber) (TABLE 4). This scale includes the density of lymphocytic infiltration, the height of villi, the depth of crypts, and the mitotic activity of the crypts. The 3a-c level is the most typical of CD. 31, 32 Analysis of autonomic nervous system and gastric myoelectrical activity ANS activity was recorded as the assessment of HRV at rest (Task Force Monitor 3040i, CNSystems, Graz, Austria). The myoelectric activity of the stomach (EGG) the study and gave their informed consent to participate in the study.
Clinical examinations A total of 68 individuals were enrolled in the study, including 34 individuals with CD (50%) and 34 healthy persons (50%). Male and female percentage did not differ significantly between the celiac and healthy groups (P = 0.272; χ 2 test). Women constituted the majority in both groups (approx. 70% in each group). The median age of celiac patients (36. and chronic viral diseases, and a history of head injury prior to the study.
Statistical analysis Correlations of anti-GM1 antibody titer, NSE, and IL-10 concentrations with disease activity measured by the modified Marsh scale (Oberhuber) and the titers of the currently used antibodies (tTG and/or EMA) were analyzed in the celiac group. The results were compared with those in the control group. The correlation between changes in EGG and HRV and the concentrations of the analyzed antibodies as well as NSE and IL-10 was assessed.
Statistical analysis was performed using Statistica 10.0 (StatSoft, Inc., Tulsa, Oklahoma, United States; the license to use the software issued for Jagiellonian University Medical College) and the free 3.2.2 version of "R" (www.r-project.org).
The level of statistical significance was set at a P value of less than 0.05.
RESULTS No significant effect of CD on the average results of NSE concentrations was observed (P = 0.66, Mann-Whitney test) (FIGURE 1). However, a significant difference between the median concentrations of anti-GM1 antibodies was noted between the groups of celiac patients and healthy controls (P <0.001, the Mann--Whitney test) (FIGURE 2A and 2B) . Celiac patients presented with a higher median level of anti-GM1 antibodies (1.38 ng/ml [0.98-2.03 ng/ml]) than healthy subjects (0.81 ng/ml [0.35-1.15 ng/ml]).
The median concentration of IL-10 in celiac patients (7 pg/ml [4.33-11.48 pg/ml]) differed significantly from that in the control group (4.27 pg/ ml [2.44-7 pg/ml]) (P = 0.010; Mann-Whitney test). Celiac patients presented with higher median levels of IL-10 compared with healthy subjects.
In the celiac group, no significant correlations between age and NSE concentrations (r = -0.02; P = 0.926) or between anti-GM1 antibodies and age were demonstrated (r = 0.15; P = 0.422). A significant, positive, and strong correlation between age and IL-10 concentrations was shown (r = 0.39; P = 0.024).
In the control group, there was no significant correlation between age and NSE concentrations (r = -0.02; P = 0.9), anti-GM1 antibodies (r = 0.18; P = 0.31), and IL-10 concentrations (r = 0.13; P = 0.52).
In patients with CD, no significant correlation was shown between concentrations of NSE and anti-GM1 antibodies (r = 0.26; P = 0.16), between concentrations of NSE and IL-10 (r = 0, P = 0.99), or between concentrations of IL-10 and anti-GM1 antibodies (r = 0.27, P = 0.14) (FIGURE 3) .
In the control group, a significant, positive, and semi-strong correlation between the levels of NSE and anti-GM1 antibodies was determined (r = 0.38; P = 0.03). In the control group, the correlations between NSE and IL-10 concentrations (r = -0. 16; P = 0.43) and between IL-10 concentrations and anti-GM1 antibodies (r = 0.05, P = 786) were nonsignificant (FIGURE 4) . The assessment of was recorded in the fasting state simultaneously using the 4-channel electrogastrography system (Polygraf NET, Medtronic, Minneapolis, Minnesota, United States).
The following HRV components were analyzed: 1 a spectrum of very low frequency (VLF) range: 0.0033-0.04 Hz; it demonstrates the variability modulated by the activity of chemoreceptors and is dependent on vasomotor and thermoregulatory reflexes involving the renin-angiotensin-aldosterone system; 2 a spectrum of low frequency (LF) range: 0.04-0.15 Hz; it is dependent on the changes in arterial pressure and oscillation of baroreceptor reflexes and is mediated by both sympathetic and parasympathetic nerve fibers; 3 a spectrum of high frequency (HF) range: 0.15-0.4 Hz; it represents the effect of breathing on the heart rhythm, which depends on the modulation of the parasympathetic system; 4 an LF/HF ratio; it expresses the interdependence of these types of vegetative modulation and depicts the mutual relation of both autonomic nervous system components; 5 total power (TP); the total power of the spectrum, it reflects the activity of the entire autonomic nervous system. EGG recordings were analyzed taking into account normogastria percentage, slow-wave coupling, and dominant power. The following exclusion criteria were introduced: concomitant neurologic disorders, malignancies, immunosuppressant treatment, medication affecting ANS activity and motility of the gastrointestinal tract, acute in 4.8% of patients (2 cases in 42 patients) in the absence of neurologic symptoms. They revealed that the concentration of antiganglioside antibodies was not dependent on adherence to a gluten-free diet. This implies that the mechanisms for the production of these antibodies are independent of gluten intake. 17 In our study group, despite the fact that all celiac patients declared compliance with dietary recommendations, histopathological changes in biopsy specimens of duodenal mucosa and/or positive results of serological tests were demonstrated in the majority of subjects. Moroever, no correlation between age and the concentration of anti-GM1 antibodies was observed. Age is considered an indirect indicator of the duration of CD. At the same time, Briani et al 17 postulated that the occurrence of neurologic disorders depends on the age of patients (children vs adults).
In our study, the correlation between age and IL-10 concentrations was found in celiac patients but not in the control group. Currently, no reports regarding this type of correlation can be found in the literature.
In celiac patients, higher concentrations of IL-10 were noted, which is in contrast to the results reported by Mizrachi et al, 36 who observed that both the peak and total concentrations of IL-10 were significantly lower in celiac patients than in healthy subjects. The reports on the concentrations of IL-10 in patients with CD remain divergent. [36] [37] [38] [39] In our study, we demonstrated higher levels of NSE in patients with CD compared to the control group, but the difference was not significant. According to available studies, NSE concentrations in the serum of celiac patients have not been investigated. However, reports on the changes in the concentrations of NSE in the intestinal tissue in the course of CD can be found. 40 An increase in NSE expression in the mucosa of the small intestine in patients with CD and Crohn disease is indicative of enhanced neuroproliferation associated with inflammation.
40
There are no studies that evaluated the correlation between HRV parameters and IL-10 and the presence of anti-GM1 antibodies or NSE.
Our analysis of the changes in HRV recordings in patients with CD showed a significant correlation between IL-10 concentration and the VLF spectrum, while no significant correlation was noted for the remaining parameters. However, some reports concerning the correlation of IL-10 and changes in the ANS are available. In a group of people with septic shock, Papaioannou et al 41 demonstrated a positive correlation between IL-10 and HF and a negative one between IL-10 and LF and IL-10 and the LF/HF ratio.
Woiciechowsky et al 42 demonstrated that activation of the sympathetic nervous system induces the systemic release of IL-10, while blocking the parasympathetic nervous system increases inflammation in the intestine. [43] [44] In a previous study, we demonstrated the predominance HRV revealed a positive correlation between IL-10 concentration and VLF (r = 0.63; P = 0.003). No correlations between the concentrations of IL-10, NSE, anti-GM1 antibodies, and EGG parameters were found.
DISCUSSION
The proposed pathomechanisms leading to neurologic complications imply immune responses and changes secondary to malabsorption of vitamins and microelements. 15, 31, 33, 34 According to Volta et al, up to 64% of patients suffering from CD with neurologic manifestation present with positive antiganglioside antibody titer.
11,17,23 Some of the postulated mechanisms responsible for the development of neurologic symptoms in CD have been identified on the basis of studies on CD as well as gluten ataxia, which belongs to the group of gluten-dependent disorders in the spectrum of gluten sensitivity. The significance of antiganglioside antibodies demonstrated in other immune neuropathies indicates that autoimmune factors are involved in the etiopathogenesis of celiac neuropathy. 11,17, 35 The results of our research have been confirmed by other studies. The presence of antiganglioside antibodies has so far been demonstrated in the course of gluten-dependent disorders such as CD or gluten ataxia.
11,17,35 Allaedini et al 11 showed the presence of antiganglioside antibodies in 6 of 21 adult patients with CD (28%), and only 1 patient (4.7%) presented with the symptoms of peripheral polyneuropathy.
11 In a study on children with CD, Briani et al 17 demonstrated the presence of IgM and IgG antiganglioside antibodies 
42-44
Gastrointestinal motility disorders accompanying CD have already been described, 22,45,46 but the pathomechanisms inducing the disorders have not been fully clarified. One hypothesis involves changes secondary to ANS disorders.
22 The correlations between the changes in gastric myoelectrical activity and the presence of antiganglioside antibodies, NSE, and IL-10 have not been analyzed yet.
Considering our current results on the correlation between IL-10 and changes in HRV recordings and our previous results, the effect of IL-10 on gastric myoelectrical activity cannot be excluded.
Owing to the pilot design of the study and the results outlined above, further studies seem warranted.
In conclusion, our study revealed that celiac patients have higher concentrations of anti-GM1 antibodies, IL-10, and NSE in comparison with the control group. The NSE level was not significantly higher in the celiac group. Moroever, changes in HRV depend on IL-10 concentrations. Finally, further studies are needed on the potential markers of ANS damage in the course of CD.
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